ADIPOQ and endometrial cancer: Adiponectin-mediated AMPK activation inhibits cell proliferation, colony formation, and adhesion and invasion properties of endometrial cancer cells [191], and inhibits angiogenesis and the neovascularisation process in mouse [177].